← Back to search
LEGACY EMANUEL HOSPITAL & HEALTH CENTER
PORTLAND, OR, 97227
Unclaimed
Other Than Small Business
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Derived from government recordsGov-sourced
Prime contracting experience
No prime contract awards on record in current sources.
Subcontracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | VETERAN PSYCHEDELIC PEER SUPPORT 1027871_LHS · Prime awardUSAspending | — | $36,412 | Dec 4, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | OVERVIEW:
UCSF HOLDS AN FDA CONTRACT ENTITLED, €œCOMMUNITY USES OF PSYCHEDELICS AND SAFETY STUDY€Ͽ½ (CUPS) WITH
THE OBJECTIVE OF USING A MULTIMODAL SET OF RESEARCH METHODS TO ASSESS FOR EMERGING TRENDS OF HARM, AND
ESTABLISHED METHODS FOR ASSURING SAFETY, AMONG PSYCHEDELIC USERS IN COMMUNITY SETTINGS TO BETTER
UNDERSTAND THE TRAJECTORY OF PSYCHEDELICS USE AND ASSOCIATED PUBLIC HEALTH CONSEQUENCES. THE SUBPROJECT
CUPS3 WILL INVESTIGATE THE ASSOCIATION OF IMPLEMENTATION OF DRUG REGULATORY CHANGES IN OREGON WITH
PSILOCYBIN-RELATED ADVERSE OUTCOMES BY COLLECTING DETAILED DE-IDENTIFIED* INDIVIDUAL PATIENT-LEVEL DATA ON
RELEVANT ENCOUNTERS FROM INSTITUTIONAL ELECTRONIC HEALTH RECORDS (EHRS).
THE SUBCONTRACTING SITE WILL PROVIDE DATA FOR THIS EFFORT. THE SUBCONTRACTING INVESTIGATOR WILL CONTRIBUTE
THEIR EFFORT AND THE EFFORT OF THEIR STAFF TO SECURING EHR DATA FROM THEIR HEALTHCARE INSTITUTION SITES LOCATED
IN THE STATE OF OREGON. IN ADDITION TO SHARING DATA, THE SUBCONTRACTOR WILL COLLABORATE ON DATA ANALYSIS AND
MANUSCRIPT PREPARATION AND CO-AUTHORSHIP. DATA OWNERSHIP IS TO BE DETERMINED BY THE APPROPRIATE DATA
USE AGREEMENT BETWEEN THE SUBCONTRACTOR AND THE PRIME CONTRACTOR (UCSF). SALARIES WILL BE LIMITED TO
FEDERAL EXECUTIVE LEVEL II.
SUMMARY OF APPROACH:
INDIVIDUAL-LEVEL PATIENT DATA FROM ENCOUNTERS THAT ARE EMERGENCY DEPARTMENT (ED) VISITS AND PSYCHIATRIC
OR MEDICAL HOSPITALIZATIONS AS DOCUMENTED IN AN ELECTRONIC HEALTH RECORD (EHR) WITH DIAGNOSTIC CODES THAT
INDICATE HALLUCINOGEN OR PSYCHEDELIC USE. DATA REQUESTED INCLUDE PATIENT DATA (E.G., DEMOGRAPHICS,
COMORBIDITIES) AND ENCOUNTER DATA (E.G., MEDICATIONS ADMINISTERED, DIAGNOSES, DISPOSITION). RETROSPECTIVE
DATA WILL BE SHARED TO ESTABLISH A BASELINE FROM WHICH TO COMPARE CURRENT AND FUTURE TRENDS; DATA WILL ALSO
BE COLLECTED AND SHARED AT QUARTERLY INTERVALS.
CONTRACT TIME PERIODS:
PERIOD 1: DECEMBER 2023 €€Œ SEP 2024,
PERIOD 2: SEP 2024 €€Œ SEP 2025, OPTION CONTINGENT UPON PRIME CONTRACTOR CUPS YEAR 3 FUNDING
FROM FDA
BUDGET AND EFFORTS ALLOCATIONS IN PERIOD 1 MAY DIFFER FROM THOSE IN PERIOD 2, AS PERIOD 1 WILL INCLUDE THE
PROJECT SET UP AND CODING.
COHORT DEFINITION:
STUDY PERIOD: JANUARY 2016 €€Œ MARCH 2025
RETROSPECTIVE DATA: JANUARY 1, 2016 €€Œ DECEMBER 31, 2023
PROSPECTIVE DATA: JANUARY 1, 2024 €€Œ SEPTEMBER 2025
SCALING AND CONTEXTUALIZING DATA:
TO NORMALIZE THE SCALE AND SCOPE OF ED VISITS FOR THE SUBCONTRACTING FACILITY, THE SUBCONTRACTER WILL ALSO
PROVIDE A MONTHLY COUNT OF ALL ED VISITS FOR EACH MONTH AS AN OVERALL COUNT ALONE.
TO CONTEXTUALIZE THE SCOPE OF THESE VISITS, THE SUBCONTRACTOR WILL ALSO PROVIDE A MONTHLY COUNT OF ED
VISITS WITH DIAGNOSIS CODES FOR RELEVANT SUBSTANCES:
ALCOHOL RELATED DISORDERS (F10.XXX)
OTHER STIMULANT RELATED DISORDERS (F15.XXX)
DATA EXTRACTION:
DATA COLLECTED FOR EACH CASE
EACH OBSERVATION WILL BE RECORDED AT THE ENCOUNTER LEVEL. THE ENCLOSED XLS CONTAINS THE DATA DICTIONARY
WITH VARIABLES REQUIRING COLLECTION FOR EACH CASE (CODEBOOK) AND A DATA ENTRY SHEET TEMPLATE AS THE OUTPUT
FILE FOR THE SUBCONTRACTOR PROVIDED DATA.
SOME EXAMPLES OF THE TYPES OF DATA REQUESTED IN THE CODEBOOK ARE AS FOLLOWS. THIS LIST IS NOT EXHAUSTIVE,
AND CONTRACTORS WILL REFERENCE THE CODEBOOK FOR THE FULL SET OF VARIABLES REQUESTED.
€¢ PATIENT DATA (E.G., AGE AT ENCOUNTER, RACE, COMORBIDITIES)
€¢ ENCOUNTER DATA (E.G., MEDICATIONS ADMINISTERED, TEST RESULTS, DIAGNOSES, DISPOSITION)
€¢ INPATIENT HOSPITALIZATION DATA, IF APPLICABLE (E.G., MEDICATIONS ADMINISTERED, DIAGNOSES,
MEDICATIONS PRESCRIBED AT DISCHARGE)
DATA SHARING:
DATA WILL BE SHARED BY SUBCONTRACTOR TO CONTRACTOR VIA SECURE EMAIL TO A UCSF-SUPPORTED BOX FOLDER OR
VIA A SECURE ONLINE PORTAL, TO BE COORDINATED AND HOSTED BY CONTRACTOR (UCSF).
RETROSPECTIVE DATA
€¢ DURING QUARTER 1 OF THE SUBCONTRACT (DECEMBER 2023 €€Œ JANUARY 2024), SUBCONTRATOR WILL BEGIN
WORK TO PROVIDE A ONE-TIME RETROSPECTIVE DATA COLLECTION REFLECTING ENCOUNTERS DURING 14908SC Parent award context Parent award agency: Department of Health and Human Services · Food and Drug Administration Parent award NAICS: 541714 Parent award performance state: CA Parent award description: BAA EETWP 65 - COMMUNITY USES OF PSYCHEDELICS AND SAFETY STUDY (CUPS) View parent award on USAspending | — | $70,125 | Aug 9, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | OVERVIEW:
UCSF HOLDS AN FDA CONTRACT ENTITLED, €œCOMMUNITY USES OF PSYCHEDELICS AND SAFETY STUDY€Ͽ½ (CUPS) WITH THE OBJECTIVE OF USING A MULTIMODAL SET OF RESEARCH METHODS TO ASSESS FOR EMERGING TRENDS OF HARM, AND ESTABLISHED METHODS FOR ASSURING SAFETY, AMONG PSYCHEDELIC USERS IN COMMUNITY SETTINGS TO BETTER
UNDERSTAND THE TRAJECTORY OF PSYCHEDELICS USE AND ASSOCIATED PUBLIC HEALTH CONSEQUENCES. THE SUBPROJECT
CUPS3 WILL INVESTIGATE THE ASSOCIATION OF IMPLEMENTATION OF DRUG REGULATORY CHANGES IN OREGON WITH PSILOCYBIN-RELATED ADVERSE OUTCOMES BY COLLECTING DETAILED DE-IDENTIFIED* INDIVIDUAL PATIENT-LEVEL DATA ON RELEVANT ENCOUNTERS FROM INSTITUTIONAL ELECTRONIC HEALTH RECORDS (EHRS).
THE SUBCONTRACTING SITE WILL PROVIDE DATA FOR THIS EFFORT. THE SUBCONTRACTING INVESTIGATOR WILL CONTRIBUTE THEIR EFFORT AND THE EFFORT OF THEIR STAFF TO SECURING EHR DATA FROM THEIR HEALTHCARE INSTITUTION SITES LOCATED IN THE STATE OF OREGON. IN ADDITION TO SHARING DATA, THE SUBCONTRACTOR WILL COLLABORATE ON DATA ANALYSIS AND MANUSCRIPT PREPARATION AND CO-AUTHORSHIP. DATA OWNERSHIP IS TO BE DETERMINED BY THE APPROPRIATE DATA
USE AGREEMENT BETWEEN THE SUBCONTRACTOR AND THE PRIME CONTRACTOR (UCSF). SALARIES WILL BE LIMITED TO FEDERAL EXECUTIVE LEVEL II.
SUMMARY OF APPROACH:
INDIVIDUAL-LEVEL PATIENT DATA FROM ENCOUNTERS THAT ARE EMERGENCY DEPARTMENT (ED) VISITS AND PSYCHIATRIC OR MEDICAL HOSPITALIZATIONS AS DOCUMENTED IN AN ELECTRONIC HEALTH RECORD (EHR) WITH DIAGNOSTIC CODES THAT INDICATE HALLUCINOGEN OR PSYCHEDELIC USE. DATA REQUESTED INCLUDE PATIENT DATA (E.G., DEMOGRAPHICS, COMORBIDITIES) AND ENCOUNTER DATA (E.G., MEDICATIONS ADMINISTERED, DIAGNOSES, DISPOSITION). RETROSPECTIVE DATA WILL BE SHARED TO ESTABLISH A BASELINE FROM WHICH TO COMPARE CURRENT AND FUTURE TRENDS; DATA WILL ALSO BE COLLECTED AND SHARED AT QUARTERLY INTERVALS.
CONTRACT TIME PERIODS:
PERIOD 1: DECEMBER 2023 €€Œ SEP 2024,
PERIOD 2: SEP 2024 €€Œ SEP 2025, OPTION CONTINGENT UPON PRIME CONTRACTOR CUPS YEAR 3 FUNDING FROM FDA
BUDGET AND EFFORTS ALLOCATIONS IN PERIOD 1 MAY DIFFER FROM THOSE IN PERIOD 2, AS PERIOD 1 WILL INCLUDE THE PROJECT SET UP AND CODING.
COHORT DEFINITION:
STUDY PERIOD: JANUARY 2016 €€Œ MARCH 2025
RETROSPECTIVE DATA: JANUARY 1, 2016 €€Œ DECEMBER 31, 2023
PROSPECTIVE DATA: JANUARY 1, 2024 €€Œ SEPTEMBER 2025
THE COHORT OF PATIENTS WILL BE IDENTIFIED BY SEARCHING ICD 10 CODES OF PATIENTS RECEIVING CARE IN THE EMERGENCY DEPARTMENTS AND RELATED FACILITIES FOR THE CONTRACTED HEALTHCARE INSTITUTION DURING THE STUDY PERIOD. THE COHORT WILL INCLUDE PATIENTS WITH HALLUCINOGEN-RELATED OR POTENTIALLY HALLUCINOGEN-RELATED VISITS BASED ON INCLUSION OF ONE OR MORE OF THE FOLLOWING IDC 10 CODES:
SCALING AND CONTEXTUALIZING DATA:
TO NORMALIZE THE SCALE AND SCOPE OF ED VISITS FOR THE SUBCONTRACTING FACILITY, THE SUBCONTRACTER WILL ALSO
PROVIDE A MONTHLY COUNT OF ALL ED VISITS FOR EACH MONTH AS AN OVERALL COUNT ALONE.
TO CONTEXTUALIZE THE SCOPE OF THESE VISITS, THE SUBCONTRACTOR WILL ALSO PROVIDE A MONTHLY COUNT OF ED
VISITS WITH DIAGNOSIS CODES FOR RELEVANT SUBSTANCES:
ALCOHOL RELATED DISORDERS (F10.XXX)
OTHER STIMULANT RELATED DISORDERS (F15.XXX)
DATA EXTRACTION:
DATA COLLECTED FOR EACH CASE
EACH OBSERVATION WILL BE RECORDED AT THE ENCOUNTER LEVEL. THE ENCLOSED XLS CONTAINS THE DATA DICTIONARY
WITH VARIABLES REQUIRING COLLECTION FOR EACH CASE (CODEBOOK) AND A DATA ENTRY SHEET TEMPLATE AS THE OUTPUT
FILE FOR THE SUBCONTRACTOR PROVIDED DATA.
SOME EXAMPLES OF THE TYPES OF DATA REQUESTED IN THE CODEBOOK ARE AS FOLLOWS. THIS LIST IS NOT EXHAUSTIVE,
AND CONTRACTORS WILL REFERENCE THE CODEBOOK FOR THE FULL SET OF VARIABLES REQUESTED.
O PATIENT DATA (E.G., AGE AT ENCOUNTER, RACE, COMORBIDITIES)
O ENCOUNTER DATA (E.G., MEDICATIONS ADMINISTERED, TEST RESULTS, DIAGNOSES, DISPOSITION)
O INPATIENT HOSPITALIZATION DATA, IF APPLICABLE (E.G., MEDICATIONS ADMINISTERED, DIAGNOSES, MEDICATIONS PRESCRIBED AT DISCHARGE)
DATA SHARING:
DATA WILL BE SHARED BY SUBCON 14908SC Parent award context Parent award agency: Department of Health and Human Services · Food and Drug Administration Parent award NAICS: 541714 Parent award performance state: CA Parent award description: BAA EETWP 65 - COMMUNITY USES OF PSYCHEDELICS AND SAFETY STUDY (CUPS) View parent award on USAspending | — | $75,057 | Mar 6, 2024 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
None recorded.